1. Home
  2. AMSC vs TYRA Comparison

AMSC vs TYRA Comparison

Compare AMSC & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

HOLD

Current Price

$42.85

Market Cap

2.0B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$28.26

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSC
TYRA
Founded
1987
2018
Country
United States
United States
Employees
400
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
AMSC
TYRA
Price
$42.85
$28.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$52.00
$47.50
AVG Volume (30 Days)
1.3M
827.7K
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1806.25
N/A
EPS
3.05
N/A
Revenue
$900,000.00
N/A
Revenue This Year
$34.98
N/A
Revenue Next Year
$21.38
N/A
P/E Ratio
$13.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.87
$8.98
52 Week High
$70.49
$40.65

Technical Indicators

Market Signals
Indicator
AMSC
TYRA
Relative Strength Index (RSI) 45.43 42.64
Support Level $28.57 $27.40
Resistance Level $63.48 $31.57
Average True Range (ATR) 3.31 1.98
MACD -0.54 0.25
Stochastic Oscillator 38.30 41.77

Price Performance

Historical Comparison
AMSC
TYRA

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: